Startseite » Forschung » Therapiestudien

Therapiestudien

 

Durch die Teilnahme an kontrollierten Studien kann das ISZM auf neue, in der klinischen Erprobung befindliche Therapien zurückgreifen. Die systematische Überprüfung von Therapien gehört zu den zentralen Zielen des Zentrums

Akutstudien

Wake up (since 04/2013)
Efficacy and safety of MRT-based thrombolysis in wake–up stroke – a randomised, double-blind, placeb-controlled trial
see clinicaltrials.gov


Studien zur Sekundärprävention

Beobachtungsstudien

DeDEMaS (since 2011)
DEterminants of DEMentia After Stroke
see clinicaltrials.gov

DEMDAS (since 12/2013)
The DZNE - Mechanisms of Dementia After Stroke Study

PROSCIS (since 2011)
Prospective Cohort with Incident Stroke
see clinicaltrials.gov

CAPIAS (since 2011)
Carotid Plaque Imaging in Acute Stroke
see clinicaltrials.gov

Suspect-CAA (since 2013)
Superficial Siderosis in Patients with suspected Cerebral Amyloid Angiopathy
see clinicaltrials.gov

SIFAP II (since 09/2007)
Characterisation of the stroke rehabilitation in young patients with Fabry diseases
see clinicaltrials.gov

 

Weitere Studien

ARUBA (since 2007)
A Randomized Multicenter Trial of Unruptured Brain AVMs
see clinicaltrials.gov

SPACE 2 (since 2010)
Stent Protected Angioplasty versus Carotid Endarterectomy

Vascamy (since 01/2013)
Vascular and Amyloid Predictors of Neurodegeneration and Cognitive Decline in Nondemented Subjects

 

Zukünftige Studien

Stroke Unit Plus (on schedule 2014)
Detecting, managing and preventing early complications after acute ischemic stroke

 

Abgeschlossene Studien (Auswahl)

ICTUS (since 03/2009)
Citicoline in the treatment of acute ischemic stroke. An international randomized multicenter placebo-controlled study

SPACE (close out 2010)
Stent-protected Percutaneous Angioplasty of the Carotid vs. Endarterectomy

PERFORM (close out 2009)
Prevention of cerebrovascular and cardiovascular Events of ischaemic origin with Terutroban in patients with a history of ischaemic stroke or transient ischaemic attack

IRIS (since 2010)
Insulin Resistance Intervention after Stroke Trial

PRIISM Feasibility Clinical Trial (close out 2011)
Percutaneous Recanalization in Ischemic Stroke Management

Crescendo (close out 2009)
Comprehensive Rimonabant Evaluation Study of Cardiovascular ENDpoints and Outcomes

TRA 2°P (close out 04/2012)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of SCH 530348 in Addition to Standard of Care in Subjects with a History of Atherosclerotic Disease: Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA2°P-TIMI 50)

SIFAP I (close out 05/2010)
Frequency of Fabry disease in an unselected group of young stroke patients

FASEP (close out 03/2012)
Fabry and Stroke, epidemiological protocol
see clinicaltrials.gov

PARIS (close out 2010)
Prospektive klinische und MRT-Studie in einer deutsch-französischen Kohorte von Cadasil- Patienten mit Notch3-Mutation